secwatch.observer — SEC 8-K summary
======================================

Issuer:     Omada Health, Inc. (OMDA)
CIK:        0001611115
Form:       8-K
Filed at:   2026-03-05T23:59:59+00:00
Accession:  0001628280-26-015153
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Omada Health Q4 revenue $76M (+58% YoY), achieves positive net income of $5M
----------------------------------------------------------------------------

- Q4 revenue $76M (+58% YoY); full-year $260M (+53% YoY). GAAP net income $5M in Q4 vs ($8M) loss prior year.
- Full-year net loss narrowed to $13M from $47M; adjusted EBITDA turned positive at $6M vs ($29M) in 2024.
- Total members reached 886,000 (+55% YoY); GLP-1 supported members tripled to over 150,000.
- Gross margin improved: Q4 GAAP 71% (up from 67%), full-year 66% (up from 61%).
- Launched new products: GLP-1 Flex Care, OmadaSpark, Meal Map, and Omada for Cholesterol (Feb 2026).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/0001628280-26-015153-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1611115/000162828026015153/omda-20260305.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-015153

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer